227 related articles for article (PubMed ID: 21863467)
1. [Cardiovascular comorbidity and its risk factors in rheumatoid arthritis].
Kleinert S; Krueger K
Z Rheumatol; 2011 Aug; 70(6):464-72. PubMed ID: 21863467
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of rheumatoid arthritis].
Bolten WW
MMW Fortschr Med; 2008 Aug; 150(32-35):50-3; quiz 54. PubMed ID: 19006884
[No Abstract] [Full Text] [Related]
3. Impact of traditional therapies and biologics on cardiovascular diseases in rheumatoid arthritis.
Boyer JF; Cantagrel A; Constantin A
Curr Vasc Pharmacol; 2008 Jul; 6(3):218-27. PubMed ID: 18673161
[TBL] [Abstract][Full Text] [Related]
4. Antibodies against cyclic citrullinated peptide don't decrease after 6 months of infliximab treatment in refractory rheumatoid arthritis.
Kolarz B; Majdan M; Dryglewska M; Darmochwal-Kolarz D
Rheumatol Int; 2011 Nov; 31(11):1439-43. PubMed ID: 20473501
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion.
Pham T; Gossec L; Constantin A; Pavy S; Bruckert E; Cantagrel A; Combe B; Flipo RM; Goupille P; Le Loët X; Mariette X; Puéchal X; Schaeverbeke T; Sibilia J; Tebib J; Wendling D; Dougados M
Joint Bone Spine; 2006 Jul; 73(4):379-87. PubMed ID: 16690341
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications.
Pieringer H; Pichler M
QJM; 2011 Jan; 104(1):13-26. PubMed ID: 21068083
[TBL] [Abstract][Full Text] [Related]
7. The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis.
Chen HA; Lin KC; Chen CH; Liao HT; Wang HP; Chang HN; Tsai CY; Chou CT
Ann Rheum Dis; 2006 Jan; 65(1):35-9. PubMed ID: 15975966
[TBL] [Abstract][Full Text] [Related]
8. Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
Ally MM; Hodkinson B; Meyer PW; Musenge E; Tintinger GR; Tikly M; Anderson R
BMC Musculoskelet Disord; 2015 May; 16():130. PubMed ID: 26021985
[TBL] [Abstract][Full Text] [Related]
9. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
10. No increased cardiovascular mortality among early rheumatoid arthritis patients: a nationwide register study in 2000-2008.
Kerola AM; Nieminen TV; Virta LJ; Kautiainen H; Kerola T; Pohjolainen T; Kauppi MJ; Puolakka K
Clin Exp Rheumatol; 2015; 33(3):391-8. PubMed ID: 25936374
[TBL] [Abstract][Full Text] [Related]
11. [Comorbidity in rheumatic diseases. Check the heart and kidneys of your arthritis patient!].
Bischoff M
MMW Fortschr Med; 2014 Nov; 156(20):30, 32. PubMed ID: 25543360
[No Abstract] [Full Text] [Related]
12. Anticitrullinated protein antibodies and rheumatoid factor are associated with increased mortality but with different causes of death in patients with rheumatoid arthritis: a longitudinal study in three European cohorts.
Ajeganova S; Humphreys JH; Verheul MK; van Steenbergen HW; van Nies JA; Hafström I; Svensson B; Huizinga TW; Trouw LA; Verstappen SM; van der Helm-van Mil AH
Ann Rheum Dis; 2016 Nov; 75(11):1924-1932. PubMed ID: 26757747
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-sparing effect of first-year anti-TNFα treatment in rheumatoid arthritis (CORPUS Cohort).
Duquenne C; Wendling D; Sibilia J; Job-Deslandre C; Guillevin L; Benichou J; Flipo RM; Guillemin F; Saraux A
Clin Exp Rheumatol; 2017; 35(4):638-646. PubMed ID: 28516872
[TBL] [Abstract][Full Text] [Related]
14. Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.
Ma MH; Scott IC; Dahanayake C; Cope AP; Scott DL
J Rheumatol; 2014 Jul; 41(7):1298-303. PubMed ID: 24931951
[TBL] [Abstract][Full Text] [Related]
15. Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis.
Katchamart W; Koolvisoot A; Aromdee E; Chiowchanwesawakit P; Muengchan C
Rheumatol Int; 2015 Oct; 35(10):1693-9. PubMed ID: 25903353
[TBL] [Abstract][Full Text] [Related]
16. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
[TBL] [Abstract][Full Text] [Related]
17. Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?
Pieringer H; Pichler M; Pohanka E; Hoppe UC
Curr Pharm Des; 2014; 20(4):486-95. PubMed ID: 23565635
[TBL] [Abstract][Full Text] [Related]
18. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial.
Kastbom A; Forslind K; Ernestam S; Geborek P; Karlsson JA; Petersson IF; Saevarsdottir S; Klareskog L; van Vollenhoven RF; Lundberg K
Ann Rheum Dis; 2016 Feb; 75(2):356-61. PubMed ID: 25550338
[TBL] [Abstract][Full Text] [Related]
19. Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment.
Di Muzio G; Perricone C; Ballanti E; Kroegler B; Greco E; Novelli L; Conigliaro P; Cipriani P; Giacomelli R; Perricone R
Int J Immunopathol Pharmacol; 2011; 24(2):357-66. PubMed ID: 21658310
[TBL] [Abstract][Full Text] [Related]
20. [Rheumatoid arthritis and cardiovascular complications].
Seidel W; Hecker M; Wagner U; Häntzschel H
Z Rheumatol; 2006 Oct; 65(6):482, 484-6. PubMed ID: 16991011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
